S488
Manufacturer Disclosure and Transparency Act; an act to amend the General Business Law — 2025-02-25 · Calendar #204
The New York State Senate passed the Manufacturer Disclosure and Transparency Act on a 49-11 vote, with the bill taking direct aim at pay-for-delay agreements that keep lower-cost generic drugs off the market. Sponsored by Sen. Fernandez, the legislation requires drug manufacturers to disclose backroom deals designed to block generic competition and inflate prescription drug costs. Fernandez argued the bill prioritizes patient access to affordable medication over corporate profits, noting that many New Yorkers cannot afford life-saving prescriptions due to anti-competitive practices rather than lack of innovation or supply. The measure will take effect 180 days after becoming law. Eleven senators voted against the bill: Ashby, Borrello, Canzoneri-Fitzpatrick, Gallivan, Griffo, Mattera, Palumbo, Stec, Tedisco, Walczyk, and Weber.
PASSED
Ayes: 49
· Nays: 11
Debate Summary
Sen. Fernandez argued that the bill addresses unaffordable prescription drug costs by targeting pay-for-delay agreements, which are backroom deals where brand-name manufacturers pay to keep lower-cost generics off the market. She contended that transparency requirements would prevent drug companies from hiding behind secrecy and prioritize patient access to affordable medication over corporate profits.
Recorded Votes
Recorded votes are predominantly dissenting (nay) votes captured from roll call records.
| Senator | Vote | Party |
|---|---|---|
| Ashby | nay | Republican |
| Borrello | nay | Republican |
| Canzoneri-Fitzpatrick | nay | Republican |
| Gallivan | nay | Republican |
| Griffo | nay | Republican |
| Mattera | nay | Republican |
| Palumbo | nay | Republican |
| Stec | nay | Republican |
| Tedisco | nay | Republican |
| Walczyk | nay | Republican |
| Weber | nay | Republican |